- £1.35bn
- £1.28bn
- -$96.90m
- 70
- 70
- 95
- 93
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 36.4 | 15.9 | 33.9 | 424 | -96.9 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6.1 | 3.47 | 3.96 | 6.95 | 6.97 |
Operating Profit | 30.3 | 12.5 | 30 | 417 | -104 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 29.7 | 12.5 | 29.9 | 417 | -103 |
Provision for Income Taxes | |||||
Net Income After Taxes | 29.7 | 12.5 | 29.9 | 417 | -103 |
Net Income Before Extraordinary Items | |||||
Net Income | 29.7 | 12.5 | 29.9 | 417 | -103 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 29.7 | 12.5 | 29.9 | 417 | -103 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.424 | 0.149 | 0.343 | 2.59 | -0.555 |
Dividends per Share |